by Amanda Conschafter, blog editor
Patient access encountered a range of challenges in 2014 – some old, some new. Here’s a look back at the top seven issues that drove physicians to advocate for their patients this year.
- The FDA accepted its first biosimilar applications, fueling debate over naming and testing requirements.
- Why Doctors Need to Know When Pharmacists Substitute Biological Medicines
- In the Name of Patient Safety
- Specialty tiers obstructed access to vital medications for patients on Affordable Care Act exchange plans.
- Specialty Tiers Hinder Access for ACA Exchange Patient
- Technology Fixes Don’t Solve Obamacare’s Access Problem
- Cancer patients faced new threats to accessing life-saving medical therapies.
- Efforts to address prescription pain pill abuse raised concerns about legitimate patient access.
- Abuse-Deterrent Opioid Formulations: Promising Technology, Unique Challenges
- Prescription Pain Medication: Preserving Patient Access While Curbing Abuse
- Thousands of premature infants entered RSV season without preventative treatment.
- Protect Premature Infants from RSV
- Perinatal Providers Stand by FDA Indication in New RSV Prevention Guidelines
- An unprecedented cure for hepatitis entered the market.
- Mid-term elections welcomed waves of new physician-legislators to statehouses across the country.
Rejoin the Institute for Patient Access blog on January 5 to follow these – and emerging – patient access issues in 2015. Happy holidays!
Want the latest updates on health policy and patient access issues?
Subscribe to the AfPA newsletter.